Trials

abound2L+

AFFINITY

ALEX

ALSYMPCA

ALTTO

ANANOVA

APHINITY

ARASENS

ARIEL3

ASCEND-1

ASCEND-2

ASCEND-4

ASSESS

Assist_FL

AURA3

AURORA

BIRCH

BISCAY

Brightness

BRIM-3

BRIM8

CABOSUN

CASTOR

CHAARTED

CheckMate 025

CheckMate 037

CheckMate 057

CheckMate 067

CheckMate 069

CheckMate 124

CheckMate 153

CheckMate 171

CheckMate 172

CheckMate 204

CheckMate 214

CheckMate 23

CheckMate 238

CheckMate 274

CheckMate153

CheckMate204

CHRONOS

CLINVO

coBRIM

COMBI-AD

COMBI-MB

CONVERT

DERMA

ECOG-AGRIN 6134

Emulsion

ENGOT-OV16/NOVA

EORTC 18071

ExteNET

FALCON

FAST

FLAURA

FOxTROT

GeparSixto

GETUG

GOG-0263

I-SPY

ICON8

IMmotion151

IMvigor010

IMvigor211

JAVELIN Lung 100

KEYNOTE-001

KEYNOTE-002

KEYNOTE-006

KEYNOTE-010

KEYNOTE-021

KEYNOTE-021G

KEYNOTE-024

KEYNOTE-029

KEYNOTE-040

KEYNOTE-045

KEYNOTE-052

KEYNOTE-057

KEYNOTE-059

KEYNOTE-100

KEYNOTE-21

KEYNOTE-40

KEYNOTE-564

LATITUDE

LORELEI

LUME BioNIS

LUME-BioNIS

LUX_Lung 3

LUX-Lung 3

LUX-Lung 6

LUX-Lung 7

MAPS2

METEOR

MINDACT

MITO-7

MONALEESA-2

MONARCH 2

MONARCH 3

MYSTIC

NCT01274182

NCT02508532

NCT02571036

NCT02847429

NEMO

NOVA

OlympiA

OpACIN

OPTiM

PACIFIC

PALETTE

PALOMA-2

PALOMA-3

PEARL

POLLUX

PREFER

PRIMUS001

PROFILE 1014

PROMIS

ProtecT

Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST

RANGE

RAPIDO

REFLECTIONS B327-02

ROMANA-1

ROMANA-2

S-TRAC

S1400A Lung-Map

Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors

SAR 3007

SCORES

SECOMBIT

SOFT

STAMPEDE

Study 19

SUMIT

TEXT

TOPARP

TRIAS 2009

YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access